GI
RCKT icon

GAMMA Investing’s Rocket Pharmaceuticals RCKT Stock Holding History

GAMMA Investing’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15K Sell
1,213
-1,066
-47% -$3.54K ﹤0.01% 3551
2026
Q1 		$8.16K Buy
2,279
+2,188
+2,404% +$8.7K ﹤0.01% 3178
2025
Q4 		$319 Buy
+91
New +$312 ﹤0.01% 3955
2025
Q3 		– Sell
-830
Closed -$2.03K – 3912
2025
Q2 		$2.03K Buy
830
+398
+92% +$2.02K ﹤0.01% 3398
2025
Q1 		$2.88K Buy
432
+170
+65% +$1.68K ﹤0.01% 3293
2024
Q4 		$3.29K Buy
262
+190
+264% +$2.86K ﹤0.01% 3063
2024
Q3 		$1.33K Buy
72
+20
+38% +$410 ﹤0.01% 3182
2024
Q2 		$1.12K Buy
52
+14
+37% +$322 ﹤0.01% 3027
2024
Q1 		$1.02K Buy
38
+15
+65% +$426 ﹤0.01% 2935
2023
Q4 		$661 Buy
+23
New +$508 ﹤0.01% 2900

Other funds holding RCKT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing's RCKT Position: Q2 2026 in Review

GAMMA Investing reduced its Rocket Pharmaceuticals (RCKT) stake by 47% in Q2 2026, selling an estimated $3.54K and leaving 1,213 shares worth $4.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3551.

GAMMA Investing first reported a position in RCKT in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.16K in Q1 2026. 11 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • GAMMA Investing held 1,213 shares of Rocket Pharmaceuticals worth $4.15K as of Q2 2026.
  • GAMMA Investing sold 1,066 Rocket Pharmaceuticals shares in Q2 2026, an estimated $3.54K.
  • Rocket Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3551 holding.
  • GAMMA Investing first reported a position in Rocket Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • GAMMA Investing's Rocket Pharmaceuticals position peaked at $8.16K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.